Berger, A. (2020). NY-BR-1 specific CAR+ T cells engineered by S/MAR vectors prove effectiveness in pre-clinical models of breast cancer. https://doi.org/10.11588/heidok.00028760
Chicago-Zitierstil (17. Ausg.)Berger, Aileen. NY-BR-1 Specific CAR+ T Cells Engineered by S/MAR Vectors Prove Effectiveness in Pre-clinical Models of Breast Cancer. Heidelberg, 2020. https://doi.org/10.11588/heidok.00028760.
MLA-Zitierstil (9. Ausg.)Berger, Aileen. NY-BR-1 Specific CAR+ T Cells Engineered by S/MAR Vectors Prove Effectiveness in Pre-clinical Models of Breast Cancer. 2020. https://doi.org/10.11588/heidok.00028760.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.